Literature DB >> 11900528

Epothilone and paclitaxel: unexpected differences in promoting the assembly and stabilization of yeast microtubules.

Claudia J Bode1, Mohan L Gupta, Emily A Reiff, Kathy A Suprenant, Gunda I Georg, Richard H Himes.   

Abstract

Paclitaxel (Taxol) and the epothilones are antimitotic agents that promote the assembly of mammalian tubulin and stabilization of microtubules. The epothilones competitively inhibit the binding of paclitaxel to mammalian brain tubulin, suggesting that the two types of compounds share a common binding site in tubulin, despite the lack of structural similarities. It is known that paclitaxel does not stabilize microtubules formed in vitro from Saccharomyces cerevisiae tubulin; thus, it would be expected that the epothilones would not affect yeast microtubules. However, we found that epothilone A and B do stimulate the formation of microtubules from purified yeast tubulin. In addition, epothilone B severely dampens the dynamics of yeast microtubules in vitro in a manner similar to the effect of paclitaxel on mammalian microtubules. We used current models describing paclitaxel and epothilone binding to mammalian beta-tubulin to explain why paclitaxel apparently fails to bind to yeast tubulin. We propose that three amino acid substitutions in the N-terminal region and at position 227 in yeast beta-tubulin weaken the interaction of the 3'-benzamido group of paclitaxel with the protein. These results also indicate that mutagenesis of yeast tubulin could help define the sites of interaction with paclitaxel and the epothilones.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11900528     DOI: 10.1021/bi0121611

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  37 in total

Review 1.  Tubulin interacting agents: novel taxanes and epothilones.

Authors:  Neeraj R Agrawal; Ram Ganapathi; Tarek Mekhail
Journal:  Curr Oncol Rep       Date:  2003-03       Impact factor: 5.075

Review 2.  Mechanisms of Taxol resistance related to microtubules.

Authors:  George A Orr; Pascal Verdier-Pinard; Hayley McDaid; Susan Band Horwitz
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867

3.  Differentiating between models of epothilone binding to microtubules using tubulin mutagenesis, cytotoxicity, and molecular modeling.

Authors:  Ruth A Entwistle; Rania S Rizk; Daniel M Cheng; Gerald H Lushington; Richard H Himes; Mohan L Gupta
Journal:  ChemMedChem       Date:  2012-07-16       Impact factor: 3.466

Review 4.  Microtubule drugs: action, selectivity, and resistance across the kingdoms of life.

Authors:  V Dostál; L Libusová
Journal:  Protoplasma       Date:  2014-03-21       Impact factor: 3.356

5.  Paclitaxel-induced microtubule stabilization causes mitotic block and apoptotic-like cell death in a paclitaxel-sensitive strain of Saccharomyces cerevisiae.

Authors:  Travis B Foland; William L Dentler; Kathy A Suprenant; Mohan L Gupta; Richard H Himes
Journal:  Yeast       Date:  2005-09       Impact factor: 3.239

6.  Chemotherapy in Androgen-Independent Prostate Cancer (AIPC): What's next after taxane progression?

Authors:  Jeanny B Aragon-Ching; William L Dahut
Journal:  Cancer Ther       Date:  2007

Review 7.  Microtubule-stabilizing drugs from marine sponges: focus on peloruside A and zampanolide.

Authors:  John H Miller; A Jonathan Singh; Peter T Northcote
Journal:  Mar Drugs       Date:  2010-03-31       Impact factor: 5.118

Review 8.  Epothilones: tubulin polymerization as a novel target for prostate cancer therapy.

Authors:  James J Lee; W Kevin Kelly
Journal:  Nat Clin Pract Oncol       Date:  2008-12-02

9.  Dissecting paclitaxel-microtubule association: quantitative assessment of the 2'-OH group.

Authors:  Shubhada Sharma; Chandraiah Lagisetti; Barbara Poliks; Robert M Coates; David G I Kingston; Susan Bane
Journal:  Biochemistry       Date:  2013-03-19       Impact factor: 3.162

10.  Ixabepilone: a new chemotherapeutic option for refractory metastatic breast cancer.

Authors:  Shannon Puhalla; Adam Brufsky
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.